Morgan Stanley
BLUE

Morgan Stanley’s bluebird bio BLUE Stock Holding History

Morgan Stanley’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,723
Closed -$140K – 8116
2025
Q1 		$140K Sell
28,723
-8,748
-23% -$52.6K ﹤0.01% 5871
2024
Q4 		$313K Sell
37,471
-10,976
-23% -$95.9K ﹤0.01% 5622
2024
Q3 		$503K Buy
48,447
+22,645
+88% +$376K ﹤0.01% 5400
2024
Q2 		$508K Sell
25,802
-38,141
-60% -$764K ﹤0.01% 5286
2024
Q1 		$1.64M Sell
63,943
-57,308
-47% -$1.47M ﹤0.01% 4694
2023
Q4 		$3.35M Buy
121,251
+100,212
+476% +$6.11M ﹤0.01% 4641
2023
Q3 		$1.28M Sell
21,039
-2,252
-10% -$158K ﹤0.01% 4651
2023
Q2 		$1.53M Sell
23,291
-2,692
-10% -$197K ﹤0.01% 4591
2023
Q1 		$1.65M Sell
25,983
-15,691
-38% -$1.79M ﹤0.01% 4570
2022
Q4 		$5.77M Buy
41,674
+18,030
+76% +$2.54M ﹤0.01% 3624
2022
Q3 		$2.99M Sell
23,644
-8,819
-27% -$998K ﹤0.01% 4122
2022
Q2 		$2.69M Sell
32,463
-46,177
-59% -$3.58M ﹤0.01% 4310
2022
Q1 		$7.63M Buy
78,640
+54,286
+223% +$7.16M ﹤0.01% 3222
2021
Q4 		$4.87M Buy
24,354
+1,613
+7% +$381K ﹤0.01% 3750
2021
Q3 		$5.63M Sell
22,741
-30,124
-57% -$8.61M ﹤0.01% 3549
2021
Q2 		$21.9M Buy
52,865
+21,887
+71% +$8.67M ﹤0.01% 2047
2021
Q1 		$12.1M Sell
30,978
-13,012
-30% -$6.41M ﹤0.01% 2452
2020
Q4 		$24.7M Buy
43,990
+26,146
+147% +$16.6M ﹤0.01% 1613
2020
Q3 		$12.5M Buy
17,844
+10,928
+158% +$8.52M ﹤0.01% 1851
2020
Q2 		$5.47M Sell
6,916
-17,074
-71% -$12.9M ﹤0.01% 2574
2020
Q1 		$14.3M Buy
23,990
+20,960
+692% +$20.4M ﹤0.01% 1514
2019
Q4 		$3.44M Sell
3,030
-331
-10% -$360K ﹤0.01% 3587
2019
Q3 		$4M Sell
3,361
-4,029
-55% -$6.15M ﹤0.01% 3113
2019
Q2 		$12.2M Sell
7,390
-8,837
-54% -$15.3M ﹤0.01% 1947
2019
Q1 		$33.1M Sell
16,227
-2,674
-14% -$4.71M 0.01% 1088
2018
Q4 		$24.3M Sell
18,901
-2,442
-11% -$3.75M 0.01% 1294
2018
Q3 		$40.4M Sell
21,343
-549
-3% -$1.13M 0.01% 1102
2018
Q2 		$44.5M Sell
21,892
-7,597
-26% -$17.3M 0.01% 986
2018
Q1 		$65.2M Buy
29,489
+18,269
+163% +$46.5M 0.02% 779
2017
Q4 		$25.9M Buy
11,220
+2,692
+32% +$5.47M 0.01% 1447
2017
Q3 		$15.2M Buy
8,528
+290
+4% +$405K ﹤0.01% 1857
2017
Q2 		$11.2M Buy
8,238
+2,161
+36% +$2.61M ﹤0.01% 2070
2017
Q1 		$7.16M Sell
6,077
-5,247
-46% -$5.35M ﹤0.01% 2520
2016
Q4 		$9.05M Buy
11,324
+7,401
+189% +$5.88M ﹤0.01% 2357
2016
Q3 		$3.44M Buy
3,923
+1,748
+80% +$1.27M ﹤0.01% 3027
2016
Q2 		$1.22M Sell
2,175
-3,490
-62% -$1.98M ﹤0.01% 3825
2016
Q1 		$3.12M Buy
5,665
+1,783
+46% +$1.1M ﹤0.01% 2945
2015
Q4 		$3.23M Buy
3,882
+774
+25% +$773K ﹤0.01% 3080
2015
Q3 		$3.44M Sell
3,108
-3,031
-49% -$5.53M ﹤0.01% 2983
2015
Q2 		$13.4M Buy
6,139
+4,142
+207% +$8.44M ﹤0.01% 1831
2015
Q1 		$3.12M Sell
1,997
-912
-31% -$1.2M ﹤0.01% 3171
2014
Q4 		$3.46M Sell
2,909
-5,097
-64% -$3.41M ﹤0.01% 3073
2014
Q3 		$3.72M Buy
8,006
+6,537
+445% +$3.02M ﹤0.01% 2887
2014
Q2 		$734K Sell
1,469
-323
-18% -$104K ﹤0.01% 4295
2014
Q1 		$528K Buy
1,792
+1,488
+489% +$451K ﹤0.01% 4517
2013
Q4 		$82K Sell
304
-691
-69% -$193K ﹤0.01% 5413
2013
Q3 		$347K Buy
+995
New +$370K ﹤0.01% 4581

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's BLUE Position: Q2 2025 in Review

Morgan Stanley sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 28,723 shares — an estimated $140K sold.

Morgan Stanley first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $65.2M in Q1 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Morgan Stanley reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 28,723 bluebird bio shares in Q2 2025, an estimated $140K.
  • Morgan Stanley first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
  • Morgan Stanley's bluebird bio position peaked at $65.2M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.